Follicopeptide
also FOL-005
- Discontinued (FOL-005) · topical · Coegin Pharma · drug programme ended; sold as a cosmetic ingredient since 2025 · trial NCT02793557 · developer page
Topical osteopontin-derived peptide (FOL-005); the phase 2 drug programme ended and it is now sold as a cosmetic ingredient
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 3
- An osteopontin‐derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor‐7 production in outer root sheath keratinocytes
- Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
- A Novel Microparticle Based Formulation for Topical Delivery of FOL-005, a Small Peptide
- Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
- An osteopontin‐derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor‐7 production in outer root sheath keratinocytes
- A Novel Microparticle Based Formulation for Topical Delivery of FOL-005, a Small Peptide
Posts 13
- Now That PP405 Hype is Gone What is Everyone Coping with as the Next Cure?
- FOL005 claims it's better than Finasteride and Minoxidil.
- Is PP405 gonna flop or what???
- Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025
- Follicum's FOL-005 is deceptive. They recently changed their website landing page.
- Follicum complete Phase 2 Study for FOL-005 Treatment for hair loss
- Any human trials on a hairloss solution ending this year?
- First patient treated in Follicum’s Phase IIa study of FOL-005 for stimulation of hair growth
- Follicopeptide ist offiziell draußen.
- Follicum veröffentlicht einige Daten aus einer früheren Phase-2a-Studie
- Here's a badly written (AI?) article about PP405 "Research: this new molecule shows TERRIFYING effectiveness against balding
- FOL-005 seems promising compared to fin and minox. Targets inflammation in a topical solution. Presentation from LSX World event.
- When will Breezula, SM04554, Follica FOL-004, follicum FOL-005 arrive in Canada?